Catalyst Wire Dossier Catalyst Wire Dossier

Glycyrrhizin (GU-01)

glycyrrhizin · University of Illinois at Chicago
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glycyrrhizin (GU-01), covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: GU-01: Glycyrrhizin in Prostate Cancer [Phase 2]

See pricing